Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carol Y. Rao is active.

Publication


Featured researches published by Carol Y. Rao.


American Journal of Tropical Medicine and Hygiene | 2010

An Investigation of a Major Outbreak of Rift Valley Fever in Kenya: 2006–2007

Patrick M. Nguku; Shanaaz Sharif; David Mutonga; Samuel Amwayi; Jared Omolo; Omar Mohammed; Eileen C. Farnon; L. Hannah Gould; Edith R. Lederman; Carol Y. Rao; Rosemary Sang; David Schnabel; Daniel R. Feikin; Allen W. Hightower; M. Kariuki Njenga; Robert F. Breiman

An outbreak of Rift Valley fever (RVF) occurred in Kenya during November 2006 through March 2007. We characterized the magnitude of the outbreak through disease surveillance and serosurveys, and investigated contributing factors to enhance strategies for forecasting to prevent or minimize the impact of future outbreaks. Of 700 suspected cases, 392 met probable or confirmed case definitions; demographic data were available for 340 (87%), including 90 (26.4%) deaths. Male cases were more likely to die than females, Case Fatality Rate Ratio 1.8 (95% Confidence Interval [CI] 1.3-3.8). Serosurveys suggested an attack rate up to 13% of residents in heavily affected areas. Genetic sequencing showed high homology among viruses from this and earlier RVF outbreaks. Case areas were more likely than non-case areas to have soil types that retain surface moisture. The outbreak had a devastatingly high case-fatality rate for hospitalized patients. However, there were up to 180,000 infected mildly ill or asymptomatic people within highly affected areas. Soil type data may add specificity to climate-based forecasting models for RVF.


The New England Journal of Medicine | 2016

Zika Virus Disease in Colombia — Preliminary Report

Oscar Pacheco; Mauricio Beltrán; Christina A. Nelson; Diana Valencia; Natalia Tolosa; Sherry L. Farr; Ana V. Padilla; Van T. Tong; Esther L. Cuevas; Andres Espinosa-Bode; Lissethe Pardo; Angélica Rico; Jennita Reefhuis; Maritza Gonzalez; Marcela Mercado; Pablo Chaparro; Mancel Martínez Duran; Carol Y. Rao; María M. Muñoz; Ann M. Powers; Claudia Cuéllar; Rita F. Helfand; Claudia Huguett; Denise J. Jamieson; Margaret A. Honein; Martha Ospina Martinez

Background Colombia began official surveillance for Zika virus disease (ZVD) in August 2015. In October 2015, an outbreak of ZVD was declared after laboratory-confirmed disease was identified in nine patients. Methods Using the national population-based surveillance system, we assessed patients with clinical symptoms of ZVD from August 9, 2015, to April 2, 2016. Laboratory test results and pregnancy outcomes were evaluated for a subgroup of pregnant women. Concurrently, we investigated reports of microcephaly for evidence of congenital ZVD. Results By April 2, 2016, there were 65,726 cases of ZVD reported in Colombia, of which 2485 (4%) were confirmed by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay. The overall reported incidence of ZVD among female patients was twice that in male patients. A total of 11,944 pregnant women with ZVD were reported in Colombia, with 1484 (12%) of these cases confirmed on RT-PCR assay. In a subgroup of 1850 pregnant women, more than 90% of women who were reportedly infected during the third trimester had given birth, and no infants with apparent abnormalities, including microcephaly, have been identified. A majority of the women who contracted ZVD in the first or second trimester were still pregnant at the time of this report. Among the cases of microcephaly investigated from January 2016 through April 2016, four patients had laboratory evidence of congenital ZVD; all were born to asymptomatic mothers who were not included in the ZVD surveillance system. Conclusions Preliminary surveillance data in Colombia suggest that maternal infection with the Zika virus during the third trimester of pregnancy is not linked to structural abnormalities in the fetus. However, the monitoring of the effect of ZVD on pregnant women in Colombia is ongoing. (Funded by Colombian Instituto Nacional de Salud and the Centers for Disease Control and Prevention.).


American Journal of Tropical Medicine and Hygiene | 2010

Risk Factors for Severe Rift Valley Fever Infection in Kenya, 2007

Amwayi S. Anyangu; L. Hannah Gould; Shahnaaz K. Sharif; Patrick M. Nguku; Jared Omolo; David Mutonga; Carol Y. Rao; Edith R. Lederman; David Schnabel; Janusz T. Paweska; Mark A. Katz; Allen W. Hightower; M. Kariuki Njenga; Daniel R. Feikin; Robert F. Breiman

A large Rift Valley fever (RVF) outbreak occurred in Kenya from December 2006 to March 2007. We conducted a study to define risk factors associated with infection and severe disease. A total of 861 individuals from 424 households were enrolled. Two hundred and two participants (23%) had serologic evidence of acute RVF infection. Of these, 52 (26%) had severe RVF disease characterized by hemorrhagic manifestations or death. Independent risk factors for acute RVF infection were consuming or handling products from sick animals (odds ratio [OR] = 2.53, 95% confidence interval [CI] = 1.78-3.61, population attributable risk percentage [PAR%] = 19%) and being a herds person (OR 1.77, 95% CI = 1.20-2.63, PAR% = 11%). Touching an aborted animal fetus was associated with severe RVF disease (OR = 3.83, 95% CI = 1.68-9.07, PAR% = 14%). Consuming or handling products from sick animals was associated with death (OR = 3.67, 95% CI = 1.07-12.64, PAR% = 47%). Exposures related to animal contact were associated with acute RVF infection, whereas exposures to mosquitoes were not independent risk factors.


Environmental Health Perspectives | 2007

Hydrophilic Fungi and Ergosterol Associated with Respiratory Illness in a Water-Damaged Building

Ju-Hyeong Park; Jean M. Cox-Ganser; Kathleen Kreiss; Sandra K. White; Carol Y. Rao

Background Damp building–related respiratory illnesses are an important public health issue. Objective We compared three respiratory case groups defined by questionnaire responses [200 respiratory cases, 123 of the respiratory cases who met the epidemiologic asthma definition, and 49 of the epidemiologic asthma cases who had current physician-diagnosed asthma with post-occupancy onset] to a comparison group of 152 asymptomatic employees in an office building with a history of water damage. Methods We analyzed dust samples collected from floors and chairs of 323 cases and comparisons for culturable fungi, ergosterol, endotoxin, and cat and dog allergens. We examined associations of total fungi, hydrophilic fungi (requiring water activity ≥ 0.9), and ergosterol with the health outcomes using logistic regression models. Results In models adjusted for demographics, respiratory illnesses showed significant linear exposure–response relationships to total culturable fungi [interquartile range odds ratios (IQR-OR) = 1.37–1.72], hydrophilic fungi (IQR-OR = 1.45–2.19), and ergosterol (IQR-OR = 1.54–1.60) in floor and chair dusts. Of three outcomes analyzed, current asthma with postoccupancy physician diagnosis was most strongly associated with exposure to hydrophilic fungi in models adjusted for ergosterol, endotoxin, and demographics (IQR-OR = 2.09 for floor and 1.79 for chair dusts). Ergosterol levels in floor dust were significantly associated with epidemiologic asthma independent of culturable fungi (IQR-OR = 1.54–1.55). Conclusions Our findings extend the 2004 conclusions of the Institute of Medicine [Human health effects associated with damp indoor environments. In: Damp Indoor Spaces and Health. Washington DC:National Academies Press, 183–269] by showing that mold levels in dust were associated with new-onset asthma in this damp indoor environment. Hydrophilic fungi and ergosterol as measures of fungal biomass may have promise as markers of risk of building-related respiratory diseases in damp indoor environments.


Morbidity and Mortality Weekly Report | 2016

Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure — United States, July 2016

Titilope Oduyebo; Irogue Igbinosa; Emily E. Petersen; Kara N. D. Polen; Satish K. Pillai; Elizabeth C. Ailes; Julie Villanueva; Kimberly Newsome; Marc Fischer; Priya M. Gupta; Ann M. Powers; Margaret A. Lampe; Susan L. Hills; Kathryn E. Arnold; Laura E. Rose; Carrie K. Shapiro-Mendoza; Charles B. Beard; Jorge L. Muñoz; Carol Y. Rao; Dana Meaney-Delman; Denise J. Jamieson; Margaret A. Honein

CDC has updated its interim guidance for U.S. health care providers caring for pregnant women with possible Zika virus exposure, to include the emerging data indicating that Zika virus RNA can be detected for prolonged periods in some pregnant women. To increase the proportion of pregnant women with Zika virus infection who receive a definitive diagnosis, CDC recommends expanding real-time reverse transcription-polymerase chain reaction (rRT-PCR) testing. Possible exposures to Zika virus include travel to or residence in an area with active Zika virus transmission, or sex* with a partner who has traveled to or resides in an area with active Zika virus transmission without using condoms or other barrier methods to prevent infection.(†) Testing recommendations for pregnant women with possible Zika virus exposure who report clinical illness consistent with Zika virus disease(§) (symptomatic pregnant women) are the same, regardless of their level of exposure (i.e., women with ongoing risk for possible exposure, including residence in or frequent travel to an area with active Zika virus transmission, as well as women living in areas without Zika virus transmission who travel to an area with active Zika virus transmission, or have unprotected sex with a partner who traveled to or resides in an area with active Zika virus transmission). Symptomatic pregnant women who are evaluated <2 weeks after symptom onset should receive serum and urine Zika virus rRT-PCR testing. Symptomatic pregnant women who are evaluated 2-12 weeks after symptom onset should first receive a Zika virus immunoglobulin (IgM) antibody test; if the IgM antibody test result is positive or equivocal, serum and urine rRT-PCR testing should be performed. Testing recommendations for pregnant women with possible Zika virus exposure who do not report clinical illness consistent with Zika virus disease (asymptomatic pregnant women) differ based on the circumstances of possible exposure. For asymptomatic pregnant women who live in areas without active Zika virus transmission and who are evaluated <2 weeks after last possible exposure, rRT-PCR testing should be performed. If the rRT-PCR result is negative, a Zika virus IgM antibody test should be performed 2-12 weeks after the exposure. Asymptomatic pregnant women who do not live in an area with active Zika virus transmission, who are first evaluated 2-12 weeks after their last possible exposure should first receive a Zika virus IgM antibody test; if the IgM antibody test result is positive or equivocal, serum and urine rRT-PCR should be performed. Asymptomatic pregnant women with ongoing risk for exposure to Zika virus should receive Zika virus IgM antibody testing as part of routine obstetric care during the first and second trimesters; immediate rRT-PCR testing should be performed when IgM antibody test results are positive or equivocal. This guidance also provides updated recommendations for the clinical management of pregnant women with confirmed or possible Zika virus infection. These recommendations will be updated when additional data become available.


Environmental Health Perspectives | 2005

Respiratory morbidity in office workers in a water-damaged building

Jean M. Cox-Ganser; Sandra K. White; Rebecca Jones; Ken Hilsbos; Eileen Storey; Paul L. Enright; Carol Y. Rao; Kathleen Kreiss

We conducted a study on building-related respiratory disease and associated social impact in an office building with water incursions in the northeastern United States. An initial questionnaire had 67% participation (888/1,327). Compared with the U.S. adult population, prevalence ratios were 2.2–2.5 for wheezing, lifetime asthma, and current asthma, 3.3 for adult-onset asthma, and 3.4 for symptoms improving away from work (p < 0.05). Two-thirds (66/103) of the adult-onset asthma arose after occupancy, with an incidence rate of 1.9/1,000 person-years before building occupancy and 14.5/1,000 person-years after building occupancy. We conducted a second survey on 140 respiratory cases, 63 subjects with fewer symptoms, and 44 comparison subjects. Health-related quality of life decreased with increasing severity of respiratory symptoms and in those with work-related symptoms. Symptom status was not associated with job satisfaction or how often jobs required hard work. Respiratory health problems accounted for one-third of sick leave, and respiratory cases with work-related symptoms had more respiratory sick days than those without work-related symptoms (9.4 vs. 2.4 days/year; p < 0.01). Abnormal lung function and/or breathing medication use was found in 67% of respiratory cases, in 38% of participants with fewer symptoms, and in 11% of the comparison group (p < 0.01), with similar results in never-smokers. Postoccupancy-onset asthma was associated with less atopy than preoccupancy-onset asthma. Occupancy of the water-damaged building was associated with onset and exacerbation of respiratory conditions, confirmed by objective medical tests. The morbidity and lost work time burdened both employees and employers.


American Journal of Tropical Medicine and Hygiene | 2010

Pathologic Studies on Suspect Animal and Human Cases of Rift Valley Fever from an Outbreak in Eastern Africa, 2006–2007

Wun-Ju Shieh; Chris D. Paddock; Edith R. Lederman; Carol Y. Rao; L. Hannah Gould; Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Peter B. Bloland; M. Kariuki Njenga; David Mutonga; Amwayi A. Samuel; Jeannette Guarner; Robert F. Breiman; Sherif R. Zaki

Rift Valley fever (RVF) is an important viral zoonotic disease in Africa with periodic outbreaks associated with severe disease, death, and economic hardship. During the 2006-2007 outbreaks in Eastern Africa, postmortem and necropsy tissue samples from 14 animals and 20 humans clinically suspected of RVF were studied with histopathologic evaluation and immunohistochemical (IHC) assays. Six animal and 11 human samples had IHC evidence of Rift Valley fever virus (RVFV) antigens. We found that extensive hepatocellular necrosis without prominent inflammatory cell infiltrates is the most distinctive histopathologic change in liver tissues infected with RVFV. Pathologic studies on postmortem tissue samples can help establish the diagnosis of RVF, differentiating from endemic diseases with clinical manifestations similar to RVF, such as malaria, leptospirosis, or yellow fever.


Environmental Research | 2008

Resident cleanup activities, characteristics of flood-damaged homes and airborne microbial concentrations in New Orleans, Louisiana, October 2005

Margaret A. Riggs; Carol Y. Rao; Clive Brown; David Van Sickle; Kristin J. Cummings; Kevin H. Dunn; James A. Deddens; Jill M. Ferdinands; David Callahan; Ronald L. Moolenaar; Lynne E. Pinkerton

BACKGROUND Flooding in the greater New Orleans (GNO) area after the hurricanes caused extensive mold growth in homes resulting in public health concerns. OBJECTIVES We conducted an environmental assessment of homes to determine the extent and type of microbial growth. METHODS We randomly selected 112 homes, stratified by water damage, and then visually assessed mold growth. Air samples from a subset of 20 homes were analyzed for culturable fungi, fungal spores, and markers of mold ((1-->3, 1-->6)-beta-D-glucans) and bacteria (endotoxin). RESULTS Visible mold growth occurred in 49 (44%) homes; 18 (16%) homes had >50% mold coverage. Flood levels were >6 ft at 20 (19%), 3-6 ft at 20 (19%), and <3 ft at 28 (26%) homes out of 107; no flooding at 39 (36%) homes. The residents spent an average of 18 h (range: 1-84) doing heavy cleaning and of those, 22 (38%) reported using an N-95 or other respirator. Visible mold growth was significantly associated with flood height 3 ft and the predominant fungi indoors were Aspergillus and Penicillium species, which were in higher concentrations in homes with a flood level 3 ft. Geometric mean (GM) levels of endotoxin were as high as 40.2 EU/m(3), while GM glucan levels were as high as 3.5 microg/m(3) even when flooding was 3 ft. CONCLUSIONS Based on our observations of visible mold, we estimated that elevated mold growth was present in 194,000 (44%) homes in the GNO area and 70,000 (16%) homes had heavy mold growth. Concentrations of endotoxin and glucans exceeded those previously associated with health effects. With such high levels of microbial growth following flooding, potentially harmful inhalation exposures can be present for persons entering or cleaning affected homes. Persons exposed to water-damaged homes should follow the CDC recommendations developed following the 2005 hurricanes for appropriate respiratory precautions.


Journal of Clinical Microbiology | 2009

Using a Field Quantitative Real-Time PCR Test To Rapidly Identify Highly Viremic Rift Valley Fever Cases

M. Kariuki Njenga; Janusz T. Paweska; Rose Wanjala; Carol Y. Rao; Matthew Weiner; Victor Omballa; Elizabeth T. Luman; David Mutonga; Shanaaz Sharif; Marcus Panning; Christian Drosten; Daniel R. Feikin; Robert F. Breiman

ABSTRACT Approximately 8% of Rift Valley fever (RVF) cases develop severe disease, leading to hemorrhage, hepatitis, and/or encephalitis and resulting in up to 50% of deaths. A major obstacle in the management of RVF and other viral hemorrhagic fever cases in outbreaks that occur in rural settings is the inability to rapidly identify such cases, with poor prognosis early enough to allow for more-aggressive therapies. During an RVF outbreak in Kenya in 2006 to 2007, we evaluated whether quantitative real-time reverse transcription-PCR (qRT-PCR) could be used in the field to rapidly identify viremic RVF cases with risk of death. In 52 of 430 RVF cases analyzed by qRT-PCR and virus culture, 18 died (case fatality rate [CFR] = 34.6%). Levels of viremia in fatal cases were significantly higher than those in nonfatal cases (mean of 105.2 versus 102.9 per ml; P < 0.005). A negative correlation between the levels of infectious virus particles and the qRT-PCR crossover threshold (CT) values allowed the use of qRT-PCR to assess prognosis. The CFR was 50.0% among cases with CT values of <27.0 (corresponding to 2.1 × 104 viral RNA particles/ml of serum) and 4.5% among cases with CT values of ≥27.0. This cutoff yielded 93.8% sensitivity and a 95.5% negative predictive value; the specificity and positive predictive value were 58% and 50%, respectively. This study shows a correlation between high viremia and fatality and indicates that qRT-PCR testing can identify nearly all fatal RVF cases.


Grana | 2004

Exposure assessment and analysis for biological agents

Kenneth Martinez; Carol Y. Rao; Nancy Clark Burton

Airborne biological agents have become prominent safety and health issues in agriculture, biotechnology, industrial settings, and the indoor environment. Each of these environments presents unique exposure concerns due to the nature of the encountered biological agent, the microbial concentrations, the modes of exposure, and the susceptibility of the exposed population. Acceptable levels of airborne microorganisms have not been established and the sampling methods and analytical techniques employed to assess airborne biocontaminants are varied and non-standardized. This paper reviews and compares the different air sampling methods for biological agents and classical analytical methods (i.e., culture and microscopy), analysis for specific microorganism constituents (i.e., ergosterol, muramic acid, glucans, allergens, mycotoxins, endotoxins) and molecular methods (i.e., polymerase chain reactions). Each of the described methods has distinct advantages and disadvantages. Selection of sampling and analytical methods depends upon the nature of the information that is sought; there is no one ideal sampling or analytical method. Combinations of sampling and analytical methods can provide a wide range of data that can be effectively tailored to many different environmental settings.

Collaboration


Dive into the Carol Y. Rao's collaboration.

Top Co-Authors

Avatar

Daniel R. Feikin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

David Mutonga

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

M. Kariuki Njenga

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott K. Fridkin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Edith R. Lederman

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jean M. Cox-Ganser

National Institute for Occupational Safety and Health

View shared research outputs
Top Co-Authors

Avatar

Judith Noble-Wang

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

L. Hannah Gould

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Margaret A. Honein

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge